Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Aichi, Japan.
Department of Gastroenterology and Hepatology, Fujita Health University School of Medicine, Aichi, Japan.
Dig Endosc. 2022 Sep;34(6):1157-1165. doi: 10.1111/den.14323. Epub 2022 May 24.
Although black stools are one of the signs of upper gastrointestinal bleeding, not all patients without hematemesis need endoscopic intervention. There is no apparent indicator to select who needs treatment thus far. The aim of this study was to establish a novel score that predicts the need for endoscopic intervention in patients with black stools without hematemesis.
We retrospectively enrolled 721 consecutive patients with black stools without hematemesis who underwent emergency endoscopy from two facilities. In the development stage (from January 2016 to December 2018), risk factors that predict the need for endoscopic intervention were determined from the data of 422 patients by multivariate logistic regression analysis, and a novel scoring system, named the modified Nagoya University score (modified N score), was developed. In the validation stage (from January 2019 to September 2020), we evaluated the diagnostic value of the modified N score for 299 patients.
Multivariate logistic regression analysis revealed four predictive factors for endoscopic intervention: syncope, the blood urea nitrogen (BUN) level, and the BUN/creatinine ratio as positive indicators and anticoagulant drug use as a negative indicator. In the validation stage, the area under the curve of the modified N score was 0.731, and the modified N score showed a sensitivity of 82.0% and a specificity of 58.8%.
Our modified N score, which consists of only four factors, can identify patients who need endoscopic intervention among those with black stools without hematemesis.
尽管黑便(柏油便)是上消化道出血的征象之一,但并非所有无呕血的患者都需要内镜干预。目前尚无明显指标来选择需要治疗的患者。本研究旨在建立一种新的评分系统,以预测无呕血黑便患者内镜干预的需求。
我们回顾性纳入了来自两家医疗机构的 721 例因黑便而接受急诊内镜检查的连续患者。在开发阶段(2016 年 1 月至 2018 年 12 月),我们通过多变量逻辑回归分析确定了 422 例患者中预测内镜干预需求的危险因素,并建立了一种新的评分系统,命名为改良名古屋大学评分(改良 N 评分)。在验证阶段(2019 年 1 月至 2020 年 9 月),我们评估了改良 N 评分对 299 例患者的诊断价值。
多变量逻辑回归分析显示,内镜干预的四个预测因素为:晕厥、血尿素氮(BUN)水平、BUN/肌酐比值(BUN/Cr)和抗凝药物使用(阳性指标)以及抗凝药物使用(阴性指标)。在验证阶段,改良 N 评分的曲线下面积为 0.731,改良 N 评分的灵敏度为 82.0%,特异度为 58.8%。
我们的改良 N 评分仅包含四个因素,可识别无呕血黑便患者中需要内镜干预的患者。